MNST
39
-7
LLY
65
-3
EXR
70
-12
QRVO
13
-5
SEE
42
-3
SRCL
40
9
GM
47
-13
OMC
58
-4
SLB
66
4
MCD
65
-2
AEP
54
-13
LRCX
56
-3
PYPL
43
-4
KO
67
-3
AZO
65
3
UAL
67
9
AMAT
59
6
PNW
52
-3
APA
42
4
KMB
65
3
MNST
39
-7
LLY
65
-3
EXR
70
-12
QRVO
13
-5
SEE
42
-3
SRCL
40
9
GM
47
-13
OMC
58
-4
SLB
66
4
MCD
65
-2
AEP
54
-13
LRCX
56
-3
PYPL
43
-4
KO
67
-3
AZO
65
3
UAL
67
9
AMAT
59
6
PNW
52
-3
APA
42
4
KMB
65
3
Financhill
Back

AbbVie Stock Predictions

Sell
50

ABBV
AbbVie

Last Price:
139.03
Seasonality Move:
0.55%

7 Day Trial

ALL ACCESS PASS

$ 7

AbbVie Stock Forecast

  • Over the next 52 weeks, AbbVie has on average historically risen by 15.8% based on the past 9 years of stock performance.
  • AbbVie has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%
  • Is AbbVie Stock Undervalued?
    The current AbbVie [ABBV] share price is $138.04. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will AbbVie Stock Go Up Next Year?

  • Over the next 52 weeks, AbbVie has on average historically risen by 15.8% based on the past 9 years of stock performance.

AbbVie Stock Rating

Sell
50
AbbVie (ABBV) is a Sell

Is AbbVie overpriced?

  • AbbVie has risen higher in 7 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 77.78%

AbbVie Stock Price History

Is ABBV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Info

Exchange:
S&P500
Country:
United States
Industry:
Drug Manufacturers - General
Sector:
Healthcare
Type:
stock
Website:
abbvieinvestor.com

52-Week Data

52-Week High:
175.91
52-Week Low:
105.56

Prediction Charts

Market Cap:
244.07B
Price in USD:
138.04
Volume:
5.35M
Beta:
0.89

Technical Analysis

SMA50:
147.72
SMA100:
152.68
SMA200:
141.68
52-Wk Change:
19.91%

Stock Predictions

  • Is AbbVie stock public?
    Yes, AbbVie is a publicly traded company.
  • What is the AbbVie stock quote today?
    The AbbVie stock price is 138.04 USD today.
  • How to buy AbbVie stock online?
    You can buy AbbVie shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-19 150.00 149.74 150.23 148.80
Jul-20 149.53 147.69 150.45 147.34
Jul-21 147.24 147.75 147.84 146.02
Jul-22 148.47 148.47 149.29 147.58
Jul-25 148.54 150.22 150.94 148.51
Jul-26 151.15 150.87 153.56 150.33
Jul-27 149.50 151.15 151.50 148.93
Jul-28 151.44 149.75 152.41 146.62
Jul-29 145.44 143.51 146.30 139.05
Aug-1 141.51 140.22 142.84 139.15
Aug-2 141.18 140.39 142.84 140.10
Aug-3 141.72 141.20 143.02 140.65
Aug-4 142.09 138.92 142.58 138.69
Aug-5 139.05 138.04 139.91 137.95

AbbVie Earnings

AbbVie Earnings Report: Per Share AbbVie Earnings Q1 Q2 Q3 and Q4 last year and next year.

AbbVie Forecast Revenue Growth

AbbVie Stock Analysis: Historical quarterly revenues per share for AbbVie and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.83 per share, an increase this year of $1.14 per share, and a decrease next year of $1.90 per share.

* AbbVie stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.